Members Login

Sep
11

New MIMS table to guide antihypertensive monitoring in primary care 9/9/20

BY CLAUDY RODHOUSE  |  POSTED IN GENERAL NEWS
New MIMS table to guide antihypertensive monitoring in primary care
By Chloe Harman on the 9 September 2020
.
Monitoring requirements for ACE inhibitors and angiotensin II antagonists are
summarised in a new MIMS table.
Prescribers can now consult a quick-reference MIMS table for a summary of monitoring
requirements for ACE inhibitors and angiotensin II antagonists.
.
.
Covering use of Athe antihypertensives in patients with heart failure, hypertension, chronic kidney disease and following MI, the table summarises the tests needed when starting the drugs, until treatment is stabilised, and subsequently.
.
Circumstances in which treatment should be stopped are also noted.
.
Recommendations in the table are summarised from NICE guidelines, CKS and SIGN.
.
The table is available online and will appear in the forthcoming September quarterly print issue of MIMS.
.
Other quick-reference drug tables recently added to MIMS include guidance on influenza vaccines for 2020/21 and a comparison of GLP-1 agonists.
.
Further information:
View ACE inhibitor and angiotensin II antagonist drug records
MIMS Cardiology Clinic
.
Click here for the source article and here for the table link
.
The link for the table alone is https://www.nice.org.uk/guidance/cg172

(Tests required for patients on renin-angiotensin inhibitors)